Internal Medicine, Hematology & Oncology · Santa Rosa, CA
NPI
1023192267
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
401 Bicentennial Way Ste 160
Santa Rosa, CA, 95403
Phone (707) 393-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.9M
1,506 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Christine Kaiser prescribed most often to Medicare patients was Anastrozole, with 132 prescriptions and refills. In total Christine Kaiser wrote 1,506 Medicare prescriptions that cost $5.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 132 | 395 | 52 | $3,688 |
| Nivestym Filgrastim-Aafi | 110 | 110 | 23 | $66K |
| Abiraterone Acetate Generic | 103 | 111 | 16 | $16K |
| Tamoxifen Citrate Generic | 98 | 321 | 41 | $2,880 |
| Hydroxyurea Generic | 63 | 178 | 20 | $2,706 |
| Prednisone Generic | 61 | 142 | 28 | $658 |
| Ondansetron Hcl Generic | 56 | 56 | 22 | $448 |
| Ibrance Palbociclib | 54 | 54 | Under 11 | $791K |
| Brukinsa Zanubrutinib | 49 | 49 | Under 11 | $587K |
| Prochlorperazine Maleate Generic | 49 | 49 | 31 | $687 |
| Lenalidomide Generic | 44 | 44 | Under 11 | $507K |
| Dexamethasone Generic | 43 | 68 | 30 | $944 |
| Imatinib Mesylate Generic | 33 | 35 | Under 11 | $1,808 |
| Granix Tbo-Filgrastim | 33 | 33 | 13 | $12K |
| Tagrisso Osimertinib Mesylate | 29 | 29 | Under 11 | $500K |
Brand drugs: 567 claims; generic drugs: 939 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Christine Kaiser were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.